Blast kills child, injures 32 Indian peacekeepers in east Congo - U.N.

November 8, 2016

Kinshasa, Nov 8: An explosion killed a child and injured 32 Indian peacekeepers in the eastern Democratic Republic of Congo city of Goma on Tuesday, the U.N. mission there said.

The blast hit the peacekeepers while they were out on a morning run in the western Goma neighbourhood of Keyshero, the mission added. The cause was not immediately clear.

Ismael Salumu, an imam at a nearby mosque, said three peacekeepers were killed. "We just heard the explosion and the cries. We then ran over to see," he told Reuters.

About 18,000 uniformed U.N. personnel operate in Congo, where millions died in regional conflicts between 1996-2003 and dozens of armed groups continue to operate.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments